SCHEMBL9717564

SCHEMBL9717564

CCCCCc1ccc(OCCCC(=O)O)c(Cl)c1Cl

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
THRB P10828 4/20 0.48
THRA P10827 2/20 0.48
LTB4R Q15722 2/20 0.46
LTB4R2 Q9NPC1 1/20 0.46
TSHR P16473 2/20 0.46
FFAR4 Q5NUL3 1/20 0.45
CYSLTR2 Q9NS75 2/20 0.43
CYSLTR1 Q9Y271 2/20 0.43
CNR2 P34972 3/20 0.42
CNR1 P21554 2/20 0.42
RAB9A P51151 1/20 0.42
PLA2G4B P0C869 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11601438 0.86 TSHR (0.61) TSHRCYSLTR2CYSLTR1
SCHEMBL28470422 0.82 TSHR (0.56) TSHR
SCHEMBL9717509 0.81 FFAR4 (0.47) THRBTHRALTB4RLTB4R2TSHR
SCHEMBL11706103 0.80 POLB (0.42) FFAR4
SCHEMBL9717557 0.78 THRB (0.64) THRBTHRATSHRFFAR4CYSLTR2
SCHEMBL7813434 0.78 HTT (0.60) THRBLTB4RLTB4R2TSHR
SCHEMBL28381703 0.77 HTT (0.59) THRBLTB4RLTB4R2TSHR
SCHEMBL9717518 0.77 THRB (0.62) THRBTHRATSHRFFAR4CYSLTR2
SCHEMBL10636268 0.75 LTB4R (0.52) THRBTHRALTB4RLTB4R2CYSLTR2
SCHEMBL25168636 0.74 LTB4R (0.77) THRBTHRALTB4RLTB4R2CYSLTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0240256-B1 COMPOUNDS USEFUL IN TREATING SICKLE CELL ANEMIA MERCK & CO. INC. (US) 1992-04-29 EP disclosed
US-4731473-A Compounds useful in treating sickle cell anemia MERCK & CO., INC. (US) 1988-03-15 US disclosed
US-4731381-A Method of treating a person for sickle cell anemia MERCK & CO., INC. (US) 1988-03-15 US disclosed
US-4699926-A Compounds useful in treating sickle cell anemia MERCK & CO., INC. (US) 1987-10-13 US disclosed
EP-0240256-A2 Compounds useful in treating sickle cell anemia MERCK & CO. INC. (US) 1987-10-07 EP disclosed